- Home
- CRSR vs ALMS Comparison
CRSR vs ALMS Comparison
Compare CRSR & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRSR
- ALMS
- Stock Information
- Founded
- CRSR 1994
- ALMS 2021
- Country
- CRSR United States
- ALMS United States
- Employees
- CRSR N/A
- ALMS N/A
- Industry
- CRSR Computer Manufacturing
- ALMS
- Sector
- CRSR Technology
- ALMS
- Exchange
- CRSR Nasdaq
- ALMS NYSE
- Market Cap
- CRSR 698.8M
- ALMS 652.3M
- IPO Year
- CRSR 2020
- ALMS 2024
- Fundamental
- Price
- CRSR $6.70
- ALMS $8.85
- Analyst Decision
- CRSR Buy
- ALMS Strong Buy
- Analyst Count
- CRSR 5
- ALMS 6
- Target Price
- CRSR $9.20
- ALMS $29.60
- AVG Volume (30 Days)
- CRSR 525.6K
- ALMS 78.8K
- Earning Date
- CRSR 11-06-2024
- ALMS 11-13-2024
- Dividend Yield
- CRSR N/A
- ALMS N/A
- EPS Growth
- CRSR N/A
- ALMS N/A
- EPS
- CRSR N/A
- ALMS N/A
- Revenue
- CRSR $1,320,042,000.00
- ALMS N/A
- Revenue This Year
- CRSR N/A
- ALMS N/A
- Revenue Next Year
- CRSR $13.57
- ALMS N/A
- P/E Ratio
- CRSR N/A
- ALMS N/A
- Revenue Growth
- CRSR N/A
- ALMS N/A
- 52 Week Low
- CRSR $5.60
- ALMS $8.23
- 52 Week High
- CRSR $15.07
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- CRSR 48.65
- ALMS N/A
- Support Level
- CRSR $6.00
- ALMS N/A
- Resistance Level
- CRSR $7.20
- ALMS N/A
- Average True Range (ATR)
- CRSR 0.40
- ALMS 0.00
- MACD
- CRSR 0.01
- ALMS 0.00
- Stochastic Oscillator
- CRSR 54.69
- ALMS 0.00
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.